Impact Factor
4.55
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
16.46
1,444 total citations
h5-index
79
h5 depth signal
Cited share
83.5%
76 of 91
Total citations
1,444
Citation footprint
Metric signal
16.44
External metric anchor
Self-citation
2.1%
30 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
312
United Kingdom
96
Australia
67
Germany
64
China
63
Citing Fields of Research
Ophthalmology
528
Cell Biology
46
Epithelial Barriers
23
Medical Physics
18
Neurodegenerative Disorders
16
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,298
Articles tracked across the journal lifetime
Indexed publication set
91
76 cited publications
Last 12 months
88
7.3 publications/month
Open access share
54.5%
48 OA publications in the last year
Leading citing country
United States
312 citing publications
Leading citing field
Ophthalmology
528 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v17n1,Jan. 1998-
v17n1,Jan. 1998-
Active Coverage
Research Focus & Classification
Indexed Subjects
Ophthalmology
Broad Categories
Ophthalmology
MeSH Descriptors
Eye Diseases
Eye
Retina
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.preteyeres.2026.101536
Open DOI
Seeing in tandem: Cis and trans-regulation of tandemly-duplicated cone opsin genes in zebrafish
02
DOI 10.1016/j.preteyeres.2026.101535
Open DOI
Ocular Changes in Human Spaceflight
03
DOI 10.1016/j.preteyeres.2026.101534
Open DOI
Cone photoreceptor quantity and distribution in human eyes: patterns, determinants and measurement frameworks
04
DOI 10.1016/j.preteyeres.2026.101533
Open DOI
Artificial intelligence for clinical decision-making in retinal disorders: From screening and diagnosis to treatment and longitudinal management
05
DOI 10.1016/j.preteyeres.2026.101532
Open DOI
From intermediate AMD to geographic atrophy: Biomarkers, endpoints, and a roadmap for next-generation clinical trials
06
DOI 10.1016/j.preteyeres.2026.101531
Open DOI
Retinopathy of prematurity in the anti-VEGF era: Screening systems and practical treatment decision-making across anti-VEGF, laser, and surgery
07
DOI 10.1016/j.preteyeres.2026.101529
Open DOI
The Virtual Eye: An integrative multiscale framework for mechanistic modelling of ocular physiology and disease
08
09
DOI 10.1016/j.preteyeres.2026.101525
Open DOI
Extending the choroidal nervous system model in central serous chorioretinopathy: A neuroendocrine–neurovascular perspective
10
DOI 10.1016/j.preteyeres.2026.101528
Open DOI
The choroidal nervous system as an integrative neuroendocrine–neurovascular node in central serous chorioretinopathy: A reply
Bibliographical & Catalog Notes
Also available online.